Nevro Corp. (NVRO)
5.84
0.00 (0.00%)
Inactive · Last trade price on Apr 2, 2025

Company Description

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally.

The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS systems.

It also offers Senza HFX iQ platform that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system.

In addition, the company provides HFX AdaptivAI, a pain management platform that powers the HFX iQ SCS system, as well as surpass surgical and percutaneous leads.

It sells its products through its direct sales force, and a network of sales agents and independent distributors.

The company was incorporated in 2006 and is based in Redwood City, California.

Nevro Corp.
Nevro logo
CountryUnited States
Founded2006
IPO DateNov 6, 2014
IndustryMedical Devices
SectorHealthcare
Employees1,099
CEOKevin Thornal

Contact Details

Address:
1800 Bridge Parkway
Redwood City, California 94065
United States
Phone650 251 0005
Websitenevro.com

Stock Details

Ticker SymbolNVRO
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001444380
CUSIP Number64157F103
ISIN NumberUS64157F1030
Employer ID56-2568057
SIC Code3841

Key Executives

NamePosition
Kevin R. ThornalPresident, Chief Executive Officer and Director
Roderick H. MacLeodSenior Vice President and Chief Financial Officer
Kashif Rashid J.D.Senior Vice President of Corporate Development and Chief Legal Officer
Greg SillerSenior Vice President and Chief Commercial Officer
Christofer ChristoforouSenior Vice President and Chief Operating Officer
Angeline C. McCabeVice President of Investor Relations and Corporate Communications
Shana D. Ross M.B.A.Senior Vice President and Chief Human Resources Officer
Dr. David Caraway M.D., Ph.D.Senior Vice President and Chief Medical Officer
Peter A. SocarrasVice President, General Counsel and Corporate Secretary

Latest SEC Filings

DateTypeTitle
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 202525-NSEFiling
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 3, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments